1. Home
  2. TWIN vs GBIO Comparison

TWIN vs GBIO Comparison

Compare TWIN & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Twin Disc Incorporated

TWIN

Twin Disc Incorporated

HOLD

Current Price

$15.45

Market Cap

224.5M

Sector

Industrials

ML Signal

HOLD

Logo Generation Bio Co.

GBIO

Generation Bio Co.

HOLD

Current Price

$5.48

Market Cap

36.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TWIN
GBIO
Founded
1918
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
224.5M
36.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
TWIN
GBIO
Price
$15.45
$5.48
Analyst Decision
Strong Buy
Buy
Analyst Count
1
5
Target Price
$12.00
$8.88
AVG Volume (30 Days)
24.5K
51.7K
Earning Date
02-04-2026
11-05-2025
Dividend Yield
1.02%
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$347,837,000.00
$15,270,000.00
Revenue This Year
$10.79
N/A
Revenue Next Year
$8.43
N/A
P/E Ratio
$640.74
N/A
Revenue Growth
14.24
N/A
52 Week Low
$6.16
$3.00
52 Week High
$17.08
$12.50

Technical Indicators

Market Signals
Indicator
TWIN
GBIO
Relative Strength Index (RSI) 48.76 53.08
Support Level $15.28 $5.20
Resistance Level $15.84 $5.54
Average True Range (ATR) 0.52 0.25
MACD -0.03 0.04
Stochastic Oscillator 34.52 69.49

Price Performance

Historical Comparison
TWIN
GBIO

About TWIN Twin Disc Incorporated

Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: